Liver Frailty Index Predicts Mortality Risk

The Liver Frailty Index can give physicians better data about the mortality risk of cirrhosis patients than just subjective data, according to a study led by Dr. Jennifer Lai of the University of California at San Francisco. In the study, published in The American Journal of Gastroenterology, 529 patients were tested on grip strength, balance

Researchers link risk of gestational diabetes and glucose intolerances to nonalcoholic fatty liver disease

A Canadian study in The American Journal of Gastroenterology showed that women with ultrasound evidence of nonalcoholic fatty liver disease (NAFLD) during their early pregnancy were more likely to develop gestational diabetes and dysglycemia in the second trimester of their pregnancy than those without NAFLD. The findings were based on 476 healthy women who underwent

“The stigma of Hep C is not getting better”

U.S. health officials said new cases of hepatitis C rose nearly 300 percent from 2010 to 2015, despite the availability of cures for the liver disease, fueled by a spike in the use of heroin and other injection drugs, according to a report released on Thursday. In 2015, the national reported rate of hepatitis C

Biomarkers of liver injury may persist after hepatitis C treatment

A biomarker of liver damage may persist after hepatitis C treatment: About one-third of patients who were successfully treated to eliminate the hepatitis C virus continued to exhibit liver inflammation, a German study showed. The findings include people who took direct-acting antiviral (DAA) drugs, the current preferred therapy for the virus. “This is the first

Access to Subspecialty Hepatology Care Increases Survival Among V.A. Patients With Liver Disease

  Access to subspecialty GI care may be difficult for patients with liver disease, but it is unknown whether access influences outcomes. A total of 28,861 patients within the Veterans Administration were studied to determine rates and predictors of access to ambulatory GI subspecialty care for patients with liver disease, and to determine whether this